, Agilemed Investment Private Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Agilemed Investments Private Limited, the Promoter of MedPlus Health Services Limited, has submitted a declaration to the exchange confirming that no new encumbrances have been created on the shares held by them in MedPlus. The filing states that no encumbrance was made either directly or indirectly, other than pledges already disclosed during Financial Year 2025-26. This is a routine regulatory compliance filing under SEBI SAST Regulations. The promoter, represented by Director Gangadi Madhukar Reddy, filed this declaration to fulfill ongoing disclosure requirements.
This is a routine compliance filing with no material impact on the stock. It confirms the promoter has not increased pledge levels beyond what was previously disclosed. Investors can note that no additional share pledging by the promoter has occurred.